Search Results - "Falla, Edel"

Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK.

Authors: McCrimmon, Rory J. Falla, Edel Sha, Jo Zhou et al.

Source: Diabetes Therapy. Dec2021, Vol. 12 Issue 12, p3217-3230. 14p.

The EU Health Technology Assessment Regulation Halo Effect: Are Cross-Functional Teams Ready?

Authors: Tanner, Sian Coady, Rebecca Lisica, Ana et al.

Source: Journal of Market Access & Health Policy. Mar2025, Vol. 13 Issue 1, p1-6. 6p.

A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany.

Authors: Xue, Weiguang Lloyd, Adam Falla, Edel et al.

Source: International Journal of Women's Health. May2019, Vol. 11, p319-331. 13p.

Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis.

Authors: Vlachaki, Ioanna Vacchelli, Matteo Zinzi, Daniela et al.

Source: BMC Infectious Diseases. 10/5/2021, Vol. 21 Issue 1, p1-12. 12p.

PD20 Real-World Evidence To Support Single Arm Trials Of Oncology Interventions: Necessity or 'NICE' (National Institute for Health and Care Excellence) to Have?

Authors: Falla, Edel Gaultney, Jennifer

Source: International Journal of Technology Assessment in Health Care; 2022 Supplement 1, Vol. 38, pS96-S97, 2p

OP68 Real-World Experience With The National Institute For Health And Care Excellence's Willingness To Accept Less Costly, Less Effective Healthcare Technologies.

Authors: Caverly, Suzanne Falla, Edel Gaultney, Jennifer et al.

Source: International Journal of Technology Assessment in Health Care; 2022 Supplement 1, Vol. 38, pS26-S26, 1p